Scarica l'app Stockscreener
4.2619
8.97%
0.3619
Precedente Chiudi:
$3.90
Aprire:
$3.92
Volume 24 ore:
125.10K
Relative Volume:
0.77
Capitalizzazione di mercato:
$202.00M
Reddito:
$7.15M
Utile/perdita netta:
$-20.60M
Rapporto P/E:
8.98
EPS:
0.4746
Flusso di cassa netto:
$-97.99M
1 W Prestazione:
+19.72%
1M Prestazione:
+8.97%
6M Prestazione:
+62.84%
1 anno Prestazione:
+175.97%
Intervallo 1D:
$3.895
$4.3375
Intervallo di 1 settimana:
$3.345
$4.3375
Portata 52W:
$1.39
$4.4799
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Nome
Whitehawk Therapeutics Inc
Settore
Industria
Telefono
551-321-2234
Indirizzo
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
4.28 | 184.07M | 7.15M | -20.60M | -97.99M | 0.4746 |
VRTX
Vertex Pharmaceuticals Inc
|
441.77 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.38 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
831.54 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.72 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.16 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-05 | Iniziato | Oppenheimer | Outperform |
| 2024-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-21 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | Iniziato | Jefferies | Buy |
| 2021-10-01 | Iniziato | Cowen | Outperform |
| 2021-09-14 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-09-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Whitehawk Therapeutics Inc Borsa (WHWK) Ultime notizie
Whitehawk Therapeutics stock initiated with outperform rating at Citizens - Investing.com
Whitehawk Therapeutics stock initiated with outperform rating at Citizens By Investing.com - Investing.com Canada
Proposed resale lists 473,902 units; insider sold 2,594 shares (WHWK) - Stock Titan
Whitehawk Therapeutics officer Ball sells $427,860 in stock - Investing.com
Whitehawk Therapeutics officer Ball sells $427,860 in stock By Investing.com - Investing.com India
Whitehawk Therapeutics (WHWK) officer sells 118,849 shares for RSU tax withholding - Stock Titan
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks - Yahoo Finance
Whitehawk Therapeutics officer Ball sells $201k in stock - Investing.com
Whitehawk Therapeutics officer Ball sells $201k in stock By Investing.com - Investing.com India
Whitehawk Therapeutics (WHWK) insider disposes 56,596 shares for tax withholding - Stock Titan
EV Market: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Stock Report & Free Community Supported Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 13.33% to 5.78 - MSN
WHWK SEC FilingsWhitehawk Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock - simplywall.st
Whitehawk Therapeutics CEO Lennon sells $49k in shares By Investing.com - Investing.com Australia
Whitehawk Therapeutics CEO Lennon sells $49k in shares - Investing.com
Whitehawk Therapeutics (WHWK) CEO sells 14,500 shares for taxes - Stock Titan
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 - PR Newswire
WHWK Stock Price, Quote & Chart | WHITEHAWK THERAPEUTICS INC (NASDAQ:WHWK) - ChartMill
Rally Mode: Can Whitehawk Therapeutics Inc sustain its profitability2026 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn
WHWK insider files Form 144 to sell 366,532 RSUs (NASDAQ: WHWK) - Stock Titan
Insider sales reported for WhiteHawk Therapeutics (NASDAQ: WHWK) during March–April 2026 - Stock Titan
Travel Stocks: Does Whitehawk Therapeutics Inc have a sustainable dividend2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Whitehawk (WHWK) CEO disposes 260K shares to satisfy tax obligations - Stock Titan
Whitehawk Therapeutics CEO Lennon sells $899k in shares By Investing.com - Investing.com Canada
WHWK | Whitehawk Therapeutics, Inc. Common FinancialsIncome Statement - Quiver Quantitative
Market Wrap: How does Whitehawk Therapeutics Inc score in quality rankings2026 Biggest Moves & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Recap: Does Whitehawk Therapeutics Inc have a sustainable dividendQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Whitehawk therapeutics CEO Lennon sells $93k in shares By Investing.com - Investing.com South Africa
Whitehawk therapeutics CEO Lennon sells $93k in shares - investing.com
WHWK: Whitehawk Therapeutics, Inc.Comparative Chart - Zacks Investment Research
Whitehawk Therapeutics (WHWK) lists 775,828 RSUs; recent 5,100-share sale - Stock Titan
Gap Down: Will Whitehawk Therapeutics Inc outperform the market in YEAR2026 Levels & Risk Controlled Swing Alerts - baoquankhu1.vn
Portfolio Update: Does Whitehawk Therapeutics Inc have a sustainable dividendWall Street Watch & Safe Entry Trade Signal Reports - baoquankhu1.vn
Whitehawk’s First-in-Human PTK7 ADC Trial Moves Ahead: What Investors Should Know - TipRanks
Nasdaq Moves: Can Whitehawk Therapeutics Inc reach resistance levels soon2026 Buyback Activity & Risk Controlled Daily Plans - baoquankhu1.vn
Aug Selloffs: Can Whitehawk Therapeutics Inc reach resistance levels soon2026 Intraday Action & Technical Buy Zone Confirmation - baoquankhu1.vn
Bank Watch: What are Whitehawk Therapeutics Incs earnings expectationsVolume Spike & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Meme Stocks: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Wall Street Zen Upgrades Whitehawk Therapeutics (NASDAQ:WHWK) to Hold - MarketBeat
Whitehawk Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 3350 | US00032Q1040 - marketscreener.com
Aug Technicals: Can Whitehawk Therapeutics Inc sustain its profitability2026 Biggest Moves & Entry Point Confirmation Signals - baoquankhu1.vn
Pullback Watch: Does Whitehawk Therapeutics Inc have a sustainable dividendWeekly Stock Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PR Newswire
Whitehawk Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aug Patterns: How does Whitehawk Therapeutics Inc score in quality rankingsMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
Inside Whitehawk's 3 next-gen cancer drug conjugates debuting at AACR 2026 - Stock Titan
Whitehawk Therapeutics Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsWHWK - GuruFocus
Whitehawk Therapeutics Inc Azioni (WHWK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):